AdaptHealth (AHCO) Income from Continuing Operations (2018 - 2026)
AdaptHealth (AHCO) posted quarterly Income from Continuing Operations of 14873000.0 for Q1 2026, down 144.66% year-over-year from 33301276.98 in Q1 2025, and up 85.36% quarter-over-quarter from 101594000.0 in Q4 2025.
AdaptHealth (AHCO) Income from Continuing Operations (2018 - 2026) Analysis & Trends
AdaptHealth's Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 14873000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 144.66% year-over-year to 14873000.0; the TTM figure through Mar 2026 stood at 74889000.0 (down 183.33% YoY), while the FY2025 annual figure was 66054000.0, down 169.66% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 14873000.0, up from 101594000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 51411000.0 in Q4 2024, with the low at 452899000.0 in Q3 2023.
- The 5-year median for Income from Continuing Operations is 15247000.0 (2022), against an average of 34579529.41.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations soared 1261.12% in 2022, then sank 15381.01% in 2023.
- AdaptHealth's Income from Continuing Operations stood at 1638000.0 in 2022, then tumbled by 15381.01% to 253579000.0 in 2023, then surged by 120.27% to 51411000.0 in 2024, then slumped by 297.61% to 101594000.0 in 2025, then surged by 85.36% to 14873000.0 in 2026.
- Business Quant data shows AHCO's Income from Continuing Operations at 14873000.0 in Q1 2026, 101594000.0 in Q4 2025, and 25750000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 201.00 Mn |
| 10 | AdaptHealth | 752.06 Mn | 708.77 Mn | 104.21 Mn | -144.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -144.11 Mn |
| Mar 31, 2026 | -14.87 Mn |
| Dec 31, 2025 | -101.59 Mn |
| Sep 30, 2025 | 25.75 Mn |
| Jun 30, 2025 | 15.83 Mn |
| Mar 31, 2025 | -6.08 Mn |
| Dec 31, 2024 | 51.41 Mn |
| Sep 30, 2024 | 23.96 Mn |
| Jun 30, 2024 | 20.58 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | -253.58 Mn |
| Sep 30, 2023 | -452.90 Mn |
| Jun 30, 2023 | 15.04 Mn |
| Mar 31, 2023 | 16.66 Mn |
| Dec 31, 2022 | -1.64 Mn |
| Sep 30, 2022 | 17.21 Mn |
| Jun 30, 2022 | 15.25 Mn |
| Mar 31, 2022 | 42.23 Mn |
| Dec 31, 2021 | 23.48 Mn |
| Sep 30, 2021 | 58.27 Mn |